News | February 08, 2022
Suven Pharma Q3FY22 PAT at Rs. 160.06 crore
Suven Pharmaceuticals has reported consolidated financial results for the period ended December 31, 2021.
Suven Pharmaceuticals has reported consolidated financial results for the period ended December 31, 2021.
Key takeaways of recent quarter & conference call highlights
Rahul has spent almost 17 years at Boston Consulting Group (BCG) where he has led the Health Care & Life Sciences practice
Mangalam Drugs and Organics Limited has reported standalone financial results for the period ended December 31, 2021
Sun Pharma Advanced Research Company has reported standalone financial results for the period ended December 31, 2021
IOL Chemicals and Pharmaceuticals has reported standalone financial results for the period ended December 31, 2021
Dishman Carbogen Amcis has reported consolidated financial results for the period ended December 31, 2021
Corbevax is administered through an intramuscular route with two doses scheduled 28 days apart and is stored between 2 degrees celsius to 8 degrees celsius
Lupin has reported consolidated financial results for the period ended December 31, 2021
The company has reported standalone financial results for the period ended December 31, 2021.
Subscribe To Our Newsletter & Stay Updated
